{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:20:22Z","timestamp":1775042422106,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Forbes Institute of the University of Michigan Rogel Cancer Center"},{"name":"Michigan Translational Research and Commercialization Program"},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201700030I"],"award-info":[{"award-number":["HHSN272201700030I"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>H84T BanLec is a molecularly engineered lectin cloned from bananas with broad-spectrum antiviral activity against several RNA viruses. H84T BanLec dimers bind glycoproteins containing high-mannose N-glycans on the virion envelope, blocking attachment, entry, uncoating, and spread. It was unknown whether H84T BanLec is effective against human herpesviruses varicella-zoster virus (VZV), human cytomegalovirus (HCMV), and herpes simplex virus 1 (HSV-1), which express high-mannose N-linked glycoproteins on their envelopes. We evaluated H84T BanLec against VZV-ORF57-Luc, TB40\/E HCMV-fLuc-eGFP, and HSV-1 R8411 in cells, skin organ culture, and mice. The H84T BanLec EC<jats:sub>50<\/jats:sub> was 0.025\u00a0\u00b5M for VZV (SI<jats:sub>50<\/jats:sub>\u2009=\u20094000) in human foreskin fibroblasts (HFFs), 0.23\u00a0\u00b5M for HCMV (SI<jats:sub>50<\/jats:sub>\u2009=\u2009441) in HFFs, and 0.33\u00a0\u00b5M for HSV-1 (SI<jats:sub>50<\/jats:sub>\u2009=\u2009308) in Vero cells. Human skin was obtained from reduction mammoplasties and prepared for culture. Skin was infected and cultured up to 14\u00a0days. H84T BanLec prevented VZV, HCMV and HSV-1 spread in skin at 10\u00a0\u00b5M in the culture medium, and also exhibited dose-dependent antiviral effects. Additionally, H84T BanLec arrested virus spread when treatment was delayed. Histopathology of HCMV-infected skin showed no overt toxicity when H84T BanLec was present in the media. In athymic nude mice with human skin xenografts (NuSkin mice), H84T BanLec reduced VZV spread when administered subcutaneously prior to intraxenograft virus inoculation. This is the first demonstration of H84T BanLec effectiveness against DNA viruses. H84T BanLec may have additional unexplored activity against other, clinically relevant, glycosylated viruses.<\/jats:p>","DOI":"10.1038\/s41598-022-05580-6","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T11:18:07Z","timestamp":1643627887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice"],"prefix":"10.1038","volume":"12","author":[{"given":"M. G.","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Markovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"5580_CR1","volume-title":"Chapter 34: Family Herpesviridae","author":"S Payne","year":"2017","unstructured":"Payne, S. Chapter 34: Family Herpesviridae (Elsevier Science, 2017)."},{"key":"5580_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12250-017-4108-2","volume":"32","author":"K Lan","year":"2017","unstructured":"Lan, K. & Luo, M. H. Herpesviruses: epidemiology, pathogenesis, and interventions. Virol. Sin. 32, 347\u2013348 (2017).","journal-title":"Virol. Sin."},{"key":"5580_CR3","first-page":"185","volume":"63","author":"Anonymous.","year":"1985","unstructured":"Anonymous.,. Prevention and control of herpesvirus diseases. Part 1. Clinical and laboratory diagnosis and chemotherapy. A WHO meeting. Bull. World Health Org. 63, 185\u2013201 (1985).","journal-title":"Bull. World Health Org."},{"key":"5580_CR4","unstructured":"McQuillan, G., Kruszon-Moran, D., Flagg, E. W., Paulose-Ram, R. Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14\u201349: United States, 2015\u20132016. NCHS Data Brief 1\u20138 (2018)."},{"key":"5580_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","volume":"65","author":"AS Lopez","year":"2016","unstructured":"Lopez, A. S., Zhang, J. & Marin, M. Epidemiology of varicella during the 2-dose varicella vaccination program\u2014United States, 2005\u20132014. MMWR Morb. Mortal. Wkly. Rep. 65, 902\u2013905 (2016).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"5580_CR6","unstructured":"Anonymous. Babies Born with CMV (Congenital CMV Infection) (National Center for Immunization and Respiratory Diseases DoVD, Centers for Disease Controla and Prevention, 2017)."},{"key":"5580_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3389\/fmicb.2019.01186","volume":"10","author":"L Stern","year":"2019","unstructured":"Stern, L. et al. Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients. Front. Microbiol. 10, 1186 (2019).","journal-title":"Front. Microbiol."},{"key":"5580_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/pathogens8040213","volume":"8","author":"H Al Mana","year":"2019","unstructured":"Al Mana, H. et al. The current status of cytomegalovirus (CMV) prevalence in the MENA region: a systematic review. Pathogens 8, 213 (2019).","journal-title":"Pathogens"},{"key":"5580_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000322141","volume":"37","author":"V Schottstedt","year":"2010","unstructured":"Schottstedt, V. et al. Human cytomegalovirus (HCMV)\u2014revised. Transfus. Med. Hemother. 37, 365\u2013375 (2010).","journal-title":"Transfus. Med. Hemother."},{"key":"5580_CR10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.clinthera.2018.07.006","volume":"40","author":"CL Poole","year":"2018","unstructured":"Poole, C. L. & James, S. H. Antiviral therapies for herpesviruses: current agents and new directions. Clin. Ther. 40, 1282\u20131298 (2018).","journal-title":"Clin. Ther."},{"key":"5580_CR11","unstructured":"Rodriguez, M., Zachary, K. C. Cidofovir: an overview. UpToDate, MS Hirsch (2016)."},{"key":"5580_CR12","unstructured":"Zachary, K. C. Acyclovir: an overview (2008)."},{"key":"5580_CR13","unstructured":"Zachary KC. 2014. Ganciclovir and valganciclovir: an overview. UpToDate, Waltham, MA. http\/\/uptodate com. Accessed on 7 Oct 2015."},{"key":"5580_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.antiviral.2017.03.007","volume":"142","author":"CA Mitchell","year":"2017","unstructured":"Mitchell, C. A., Ramessar, K. & O\u2019Keefe, B. R. Antiviral lectins: selective inhibitors of viral entry. Antiviral Res. 142, 37\u201354 (2017).","journal-title":"Antiviral Res."},{"key":"5580_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.cell.2015.09.056","volume":"163","author":"MD Swanson","year":"2015","unstructured":"Swanson, M. D. et al. Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activity. Cell 163, 746\u2013758 (2015).","journal-title":"Cell"},{"key":"5580_CR16","doi-asserted-by":"publisher","first-page":"8646","DOI":"10.1074\/jbc.M109.034926","volume":"285","author":"MD Swanson","year":"2010","unstructured":"Swanson, M. D., Winter, H. C., Goldstein, I. J. & Markovitz, D. M. A lectin isolated from bananas is a potent inhibitor of HIV replication. J. Biol. Chem. 285, 8646\u20138655 (2010).","journal-title":"J. Biol. Chem."},{"key":"5580_CR17","doi-asserted-by":"publisher","first-page":"18817","DOI":"10.3390\/molecules191118817","volume":"19","author":"SS Singh","year":"2014","unstructured":"Singh, S. S., Devi, S. K. & Ng, T. B. Banana lectin: a brief review. Molecules 19, 18817\u201318827 (2014).","journal-title":"Molecules"},{"key":"5580_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.23822\/EurAnnACI.1764-1489.64","volume":"50","author":"N Krithika","year":"2018","unstructured":"Krithika, N., Pramod, S. N., Mahesh, P. A. & Venkatesh, Y. P. Banana lectin (BanLec) induces non-specific activation of basophils and mast cells in atopic subjects. Eur. Ann. Allergy Clin. Immunol. 50, 243\u2013253 (2018).","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"5580_CR19","unstructured":"Swanson, M. D. Molecular engineering of a banana lectin that inhibits HIV-1 replication (2010)."},{"key":"5580_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.str.2017.03.015","volume":"25","author":"JTS Hopper","year":"2017","unstructured":"Hopper, J. T. S. et al. The tetrameric plant lectin BanLec neutralizes HIV through bidentate binding to specific viral glycans. Structure 25, 773\u2013782 (2017).","journal-title":"Structure"},{"key":"5580_CR21","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1073\/pnas.1915152117","volume":"117","author":"EM Coves-Datson","year":"2020","unstructured":"Coves-Datson, E. M. et al. A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo. Proc. Natl. Acad. Sci. U S A 117, 2122\u20132132 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"5580_CR22","doi-asserted-by":"publisher","first-page":"e0007595","DOI":"10.1371\/journal.pntd.0007595","volume":"13","author":"EM Coves-Datson","year":"2019","unstructured":"Coves-Datson, E. M. et al. Inhibition of ebola virus by a molecularly engineered banana lectin. PLoS Negl. Trop. Dis. 13, e0007595 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5580_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1851303:1-19","author":"KB Lokhande","year":"2020","unstructured":"Lokhande, K. B. et al. Sensing the interactions between carbohydrate-binding agents and N-linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation studies. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1851303:1-19 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"5580_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ijbiomac.2020.04.125","volume":"157","author":"LJ de Camargo","year":"2020","unstructured":"de Camargo, L. J. et al. Antiviral activity of native banana lectin against bovine viral diarrhea virus and bovine alphaherpesvirus type 1. Int. J. Biol. Macromol. 157, 569\u2013576 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"5580_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/biom11020180","volume":"11","author":"Z Lopandic","year":"2021","unstructured":"Lopandic, Z. et al. BanLec-eGFP chimera as a tool for evaluation of lectin binding to high-mannose glycans on microorganisms. Biomolecules 11, 180 (2021).","journal-title":"Biomolecules"},{"key":"5580_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41598-020-80577-7","volume":"11","author":"EM Coves-Datson","year":"2021","unstructured":"Coves-Datson, E. M. et al. Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity. Sci. Rep. 11, 656 (2021).","journal-title":"Sci. Rep."},{"key":"5580_CR27","doi-asserted-by":"publisher","first-page":"e1004784","DOI":"10.1371\/journal.ppat.1004784","volume":"11","author":"I Bagdonaite","year":"2015","unstructured":"Bagdonaite, I. et al. A strategy for O-glycoproteomics of enveloped viruses\u2013the O-glycoproteome of herpes simplex virus type 1. PLoS Pathog. 11, e1004784 (2015).","journal-title":"PLoS Pathog."},{"key":"5580_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0042-6822(83)90533-0","volume":"131","author":"F Serafini-Cessi","year":"1983","unstructured":"Serafini-Cessi, F., Dall\u2019Olio, F., Scannavini, M. & Campadelli-Fiume, G. Processing of herpes simplex virus-1 glycans in cells defective in glycosyl transferases of the Golgi system: relationship to cell fusion and virion egress. Virology 131, 59\u201370 (1983).","journal-title":"Virology"},{"key":"5580_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/jvi.43.3.1061-1071.1982","volume":"43","author":"G Campadelli-Fiume","year":"1982","unstructured":"Campadelli-Fiume, G., Poletti, L., Dall\u2019Olio, F. & Serafini-Cessi, F. Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I. J. Virol. 43, 1061\u20131071 (1982).","journal-title":"J. Virol."},{"key":"5580_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1128\/jvi.51.3.838-844.1984","volume":"51","author":"F Serafini-Cessi","year":"1984","unstructured":"Serafini-Cessi, F., Dall\u2019Olio, F., Pereira, L. & Campadelli-Fiume, G. Processing of N-linked oligosaccharides from precursor- to mature-form herpes simplex virus type 1 glycoprotein gC. J. Virol. 51, 838\u2013844 (1984).","journal-title":"J. Virol."},{"key":"5580_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virol.2015.04.005","volume":"483","author":"S Luo","year":"2015","unstructured":"Luo, S. et al. Contribution of N-linked glycans on HSV-2 gB to cell-cell fusion and viral entry. Virology 483, 72\u201382 (2015).","journal-title":"Virology"},{"key":"5580_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/glycob\/9.1.73","volume":"9","author":"S Olofsson","year":"1999","unstructured":"Olofsson, S. et al. The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC. Glycobiology 9, 73\u201381 (1999).","journal-title":"Glycobiology"},{"key":"5580_CR33","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1128\/JVI.00087-09","volume":"83","author":"Q Fan","year":"2009","unstructured":"Fan, Q., Lin, E., Satoh, T., Arase, H. & Spear, P. G. Differential effects on cell fusion activity of mutations in herpes simplex virus 1 glycoprotein B (gB) dependent on whether a gD receptor or a gB receptor is overexpressed. J. Virol. 83, 7384\u20137390 (2009).","journal-title":"J. Virol."},{"key":"5580_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0042-6822(91)90766-5","volume":"185","author":"H Ghiasi","year":"1991","unstructured":"Ghiasi, H., Nesburn, A. B. & Wechsler, S. L. Cell surface expression of herpes simplex virus type 1 glycoprotein H in recombinant baculovirus-infected cells. Virology 185, 187\u2013194 (1991).","journal-title":"Virology"},{"key":"5580_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/ijms20040954","volume":"20","author":"R Norden","year":"2019","unstructured":"Norden, R. et al. Recombinant glycoprotein E of Varicella zoster virus contains glycan-peptide motifs that modulate B cell epitopes into discrete immunological signatures. Int. J. Mol. Sci. 20, 924 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"5580_CR36","doi-asserted-by":"publisher","first-page":"19833","DOI":"10.1074\/jbc.M114.635508","volume":"290","author":"T Suenaga","year":"2015","unstructured":"Suenaga, T. et al. Sialic acids on varicella-zoster virus glycoprotein B are required for cell-cell fusion. J. Biol. Chem. 290, 19833\u201319843 (2015).","journal-title":"J. Biol. Chem."},{"key":"5580_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0042-6822(85)90201-6","volume":"145","author":"CM Edson","year":"1985","unstructured":"Edson, C. M. et al. Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material. Virology 145, 62\u201371 (1985).","journal-title":"Virology"},{"key":"5580_CR38","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/emboj\/20.7.1573","volume":"20","author":"A Rehm","year":"2001","unstructured":"Rehm, A., Stern, P., Ploegh, H. L. & Tortorella, D. Signal peptide cleavage of a type I membrane protein, HCMV US11, is dependent on its membrane anchor. EMBO J. 20, 1573\u20131582 (2001).","journal-title":"EMBO J."},{"key":"5580_CR39","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1128\/JVI.73.5.3886-3892.1999","volume":"73","author":"MT Huber","year":"1999","unstructured":"Huber, M. T. & Compton, T. Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus. J. Virol. 73, 3886\u20133892 (1999).","journal-title":"J. Virol."},{"key":"5580_CR40","doi-asserted-by":"publisher","first-page":"11881","DOI":"10.1128\/JVI.74.24.11881-11892.2000","volume":"74","author":"M Mach","year":"2000","unstructured":"Mach, M., Kropff, B., Dal Monte, P. & Britt, W. Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73). J. Virol. 74, 11881\u201311892 (2000).","journal-title":"J. Virol."},{"issue":"Pt 6","key":"5580_CR41","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1099\/0022-1317-69-6-1205","volume":"69","author":"DR Gretch","year":"1988","unstructured":"Gretch, D. R., Gehrz, R. C. & Stinski, M. F. Characterization of a human cytomegalovirus glycoprotein complex (gcI). J. Gen. Virol. 69(Pt 6), 1205\u20131215 (1988).","journal-title":"J. Gen. Virol."},{"key":"5580_CR42","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1128\/JVI.02666-06","volume":"81","author":"Z Zhang","year":"2007","unstructured":"Zhang, Z. et al. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J. Virol. 81, 9024\u20139033 (2007).","journal-title":"J. Virol."},{"key":"5580_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.antiviral.2010.03.007","volume":"86","author":"J Rowe","year":"2010","unstructured":"Rowe, J., Greenblatt, R. J., Liu, D. & Moffat, J. F. Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice. Antiviral Res. 86, 276\u2013285 (2010).","journal-title":"Antiviral Res."},{"key":"5580_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01082-20","author":"MG Lloyd","year":"2020","unstructured":"Lloyd, M. G. et al. A novel human skin tissue model to study varicella-zoster virus and human cytomegalovirus. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01082-20 (2020).","journal-title":"J. Virol."},{"key":"5580_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.antiviral.2008.01.155","volume":"79","author":"DC Quenelle","year":"2008","unstructured":"Quenelle, D. C. et al. Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models. Antiviral Res. 79, 133\u2013135 (2008).","journal-title":"Antiviral Res."},{"key":"5580_CR46","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1128\/AAC.48.12.4745-4753.2004","volume":"48","author":"ER Kern","year":"2004","unstructured":"Kern, E. R. et al. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. Antimicrob. Agents Chemother. 48, 4745\u20134753 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5580_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/rmv.377","volume":"13","author":"NL Cole","year":"2003","unstructured":"Cole, N. L. & Grose, C. Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus. Rev. Med. Virol. 13, 207\u2013222 (2003).","journal-title":"Rev. Med. Virol."},{"key":"5580_CR48","doi-asserted-by":"publisher","first-page":"77R","DOI":"10.1093\/glycob\/cwg075","volume":"13","author":"ES Trombetta","year":"2003","unstructured":"Trombetta, E. S. The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis. Glycobiology 13, 77R-91R (2003).","journal-title":"Glycobiology"},{"key":"5580_CR49","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1073\/pnas.78.8.5202","volume":"78","author":"L Pereira","year":"1981","unstructured":"Pereira, L., Dondero, D., Norrild, B. & Roizman, B. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells. Proc. Natl. Acad. Sci. U S A 78, 5202\u20135206 (1981).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"5580_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijbiomac.2016.04.049","volume":"89","author":"AC Sansone","year":"2016","unstructured":"Sansone, A. C., Sansone, M., Dos Santos Dias, C. T. & Oliveira do Nascimento, J. R. Oral administration of banana lectin modulates cytokine profile and abundance of T-cell populations in mice. Int. J. Biol. Macromol. 89, 19\u201324 (2016).","journal-title":"Int. J. Biol. Macromol."},{"key":"5580_CR51","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/aps.2012.51","volume":"33","author":"L Zhao","year":"2012","unstructured":"Zhao, L., Ren, T. H. & Wang, D. D. Clinical pharmacology considerations in biologics development. Acta Pharmacol. Sin. 33, 1339\u20131347 (2012).","journal-title":"Acta Pharmacol. Sin."},{"key":"5580_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2018.183","volume":"18","author":"AC Anselmo","year":"2019","unstructured":"Anselmo, A. C., Gokarn, Y. & Mitragotri, S. Non-invasive delivery strategies for biologics. Nat. Rev. Drug Discov. 18, 19\u201340 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"5580_CR53","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2741\/2750","volume":"13","author":"A Pusztai","year":"2008","unstructured":"Pusztai, A., Bardocz, S. & Ewen, S. W. Uses of plant lectins in bioscience and biomedicine. Front. Biosci. 13, 1130\u20131140 (2008).","journal-title":"Front. Biosci."},{"key":"5580_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/v8120331","volume":"8","author":"C Barton","year":"2016","unstructured":"Barton, C., Kouokam, J. C., Hurst, H. & Palmer, K. E. Pharmacokinetics of the antiviral lectin griffithsin administered by different routes indicates multiple potential uses. Viruses 8, 331 (2016).","journal-title":"Viruses"},{"key":"5580_CR55","doi-asserted-by":"publisher","first-page":"13200","DOI":"10.1128\/JVI.01148-07","volume":"81","author":"BK Tischer","year":"2007","unstructured":"Tischer, B. K. et al. A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J. Virol. 81, 13200\u201313208 (2007).","journal-title":"J. Virol."},{"issue":"Pt 11","key":"5580_CR56","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1099\/0022-1317-80-11-2867","volume":"80","author":"C Sinzger","year":"1999","unstructured":"Sinzger, C. et al. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol. 80(Pt 11), 2867\u20132877 (1999).","journal-title":"J. Gen. Virol."},{"key":"5580_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.antiviral.2016.09.012","volume":"135","author":"EA Pitt","year":"2016","unstructured":"Pitt, E. A. et al. The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro. Antiviral Res. 135, 15\u201323 (2016).","journal-title":"Antiviral Res."},{"key":"5580_CR58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1084\/jem.20081633","volume":"206","author":"M Haniffa","year":"2009","unstructured":"Haniffa, M. et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J. Exp. Med. 206, 371\u2013385 (2009).","journal-title":"J. Exp. Med."},{"key":"5580_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.antiviral.2014.07.007","volume":"110","author":"C De","year":"2014","unstructured":"De, C. et al. beta-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism. Antiviral Res. 110, 10\u201319 (2014).","journal-title":"Antiviral Res."},{"key":"5580_CR60","doi-asserted-by":"publisher","first-page":"11501","DOI":"10.1128\/JVI.79.17.11501-11506.2005","volume":"79","author":"SL Taylor","year":"2005","unstructured":"Taylor, S. L. & Moffat, J. F. Replication of varicella-zoster virus in human skin organ culture. J. Virol. 79, 11501\u201311506 (2005).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05580-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:24:54Z","timestamp":1669328694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5580"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05580-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1641"}}